Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,033-1,044 of 4,306
Behavioral study icon
UnknownNCT06494124

TACS vs tDCS for schizophrenia

This study has an unknown status in India. It is testing tACS vs tDCS for schizophrenia.

In Bhubaneswar
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 60 Years
Countries
India
Sponsor
All India Institute of Medical Sciences, Bhubaneswar
Condition
Schizophrenia
Drug study icon
CompletedNCT00202007

Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia

This study is completed in China. It focuses on schizophrenia.

Multiple locations, including Guangzhou
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
China
Sponsor
Otsuka Beijing Research Institute
Condition
Schizophrenia
Behavioral study icon
CompletedNCT02678858

Efficacy of ISST in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Alzey
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
Germany
Sponsor
Heinrich-Heine University, Duesseldorf
Condition
Schizophrenia
Behavioral study icon
CompletedNCT00587561

Efficacy of Social Cognition Training in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including New Haven
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
VA Connecticut Healthcare System
Condition
Schizophrenia
Device study icon
CompletedNCT05282329

Efficacy of tACS for Treatment of Auditory Hallucinations in Refractory Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Tianjin
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 70 Years
Countries
China
Sponsor
Tianjin Anding Hospital
Condition
Schizophrenia
Drug study icon
TerminatedNCT03896945

Efficacy, Safety, and Tolerability of AVP-786 for Negative Symptoms of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States, Bulgaria, Poland
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT05545111

Safety study of NBI-1117568 in schizophrenia

This study is completed in the United States. It is testing NBI-1117568 for schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Neurocrine Biosciences
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.